Affirm Stock Surges – Will the Momentum Last?

This afternoon we watched Affirm rise 13.5% to a price of $33.9 per share. The Large-Cap Diversified Financial company is now trading -5.1% below its average target price of $35.72. Analysts have set target prices ranging from $20.0 to $65.0 per share for Affirm, and have given the stock an average rating of hold.

The stock has an above average percentage of its shares sold short at 12.9%, and a short ratio of 4.03. The company's insiders own 4.83% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 83.0% of Affirm's shares being owned by this investor type.

Institutions Invested in Affirm

Date Reported Holder Percentage Shares Value
2024-03-31 Morgan Stanley 12% 30,569,187 $1,036,225,168
2024-03-31 Vanguard Group Inc 8% 20,823,803 $705,879,053
2024-03-31 Capital Research Global Investors 7% 19,419,985 $658,292,850
2024-03-31 Capital World Investors 7% 19,079,071 $646,736,649
2024-03-31 Baillie Gifford and Company 7% 18,732,407 $634,985,536
2024-03-31 Blackrock Inc. 4% 9,965,847 $337,819,304
2024-03-31 Shaw D.E. & Co., Inc. 3% 9,071,991 $307,519,640
2024-03-31 Geode Capital Management, LLC 1% 3,821,486 $129,539,590
2024-03-31 State Street Corporation 1% 3,760,116 $127,459,288
2024-03-31 Two Sigma Advisers, LP 1% 3,556,500 $120,557,174

Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on Affirm.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.